Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/1993
02/10/1993EP0526695A1 Stabilized PVP-I solutions
02/10/1993EP0526666A1 Solid lipid microspheres having a narrow size distribution and method for producing them
02/10/1993EP0526578A1 Composition and method for topical treatment of damaged or diseased tissue
02/10/1993EP0526566A1 Treatment of erectile dysfunction
02/10/1993EP0526540A1 Use of 5-ht 4? receptor antagonists in the treatment of arrythmias and stroke
02/10/1993EP0526481A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations.
02/10/1993EP0493489A4 Film-enrobed unitary-core medicament and the like
02/10/1993EP0445156B1 Agents for treating chronic inflammatory diseases of the intestines
02/10/1993CN1068741A Healthy pack with medicine
02/10/1993CN1068739A Improved oral dosing formulations of dideoxy purine nucleosides
02/10/1993CN1068736A Process for preparing antifungal composition for external application
02/10/1993CN1068735A Stable compositions for parenteral adiministration and thier use
02/10/1993CN1068734A Therapeutic agent
02/10/1993CN1068733A Mouth protection liquid for parodontosis (canned and self-spraying type)
02/09/1993US5185373 Inhibition of thermal degradation of ibuprofen
02/09/1993US5185372 Sealed container of solution of retinol palmitate, boric acid, nonionic surfactant, chelating agent, preservative; adjusted pH; topical treatment of dry eye syndrome
02/09/1993US5185336 Spray drying aqueous solution or suspension
02/09/1993US5185335 N-(4-piperodinyl)(dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
02/09/1993US5185159 Pharmaceutical composition based on valproic acid and a process for preparing it
02/09/1993US5185158 Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
02/09/1993US5185157 Treatment of refractory Eosinophilia-Myalgia Syndrome with L-tryptophan composition
02/09/1993US5185154 Dissolving charged or uncharged phospholipids, depositing on patterned silicon wafer, drying formed film, adding water to form vesicles
02/09/1993US5185153 Agents effecting the lysis of oral bacteria
02/09/1993US5185152 Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
02/09/1993US5185099 Visco-elastic, isotropic materials based on water, fluorinate sufactants and fluorinated oils, process for their preparation, and their use in various fields, such as optics, pharmacology and electrodynamics
02/09/1993CA1313497C Administrative and dosage from drug active agents, reagents or the like and process for the preparation thereof
02/06/1993CA2075340A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
02/04/1993WO1993003714A2 Method for treatment of metabolic disorders
02/04/1993WO1993002039A1 Alkyl galactarates, their preparation methods and use
02/04/1993WO1993001841A1 Improvements in antibiotic-containing acrylic beads
02/04/1993WO1993001831A1 Induction of cytotoxic t-lymphocyte responses
02/04/1993WO1993001814A1 Oxicam or oxicam derivatives-containing ophthalmic compositions
02/04/1993WO1993001811A1 Method of preparing a sterile-filterable solution of an active substance
02/04/1993WO1993001809A1 Pharmaceutical formulations comprised of micronised halofantrine
02/04/1993WO1993001807A1 Transdermal delivery device
02/04/1993WO1993001806A1 Encapsulated perfluorocarbons
02/04/1993WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor
02/04/1993WO1993001801A1 Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
02/04/1993WO1993001800A1 Therapeutic compositions and methods
02/04/1993WO1993001799A1 Process for the manufacture of bioerodible poly(orthoester)s and polyacetals
02/04/1993WO1993001798A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses
02/04/1993WO1993001793A1 Liquid deodorant compositions
02/04/1993WO1993001790A1 Dental tray
02/04/1993WO1993001776A1 Device for administering bimakalim transdermally
02/04/1993WO1993001746A1 Electrically conductive gel composition
02/04/1993DE4210165A1 Transdermale therapeutische systeme Transdermal therapeutic systems
02/04/1993DE4125400A1 Verwendung von kollagen zur behandlung von degenerativen gelenkprozessen Use of collagen for the treatment of degenerative joint processes
02/04/1993DE4125332A1 Emulgatorkonzentrat Emulsifying
02/04/1993DE4125255A1 Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung Prostaglandin E (Down Arrow) 1 (down arrow) formulation,
02/04/1993DE4125048A1 Retard pharmaceutical prepn. for periodontitis treatment - contains anti-periodontitis drug esp. metronidazole, in cationic (meth)acrylic] polymer matrix pref. used as film strip
02/04/1993CA2114836A1 Lipid vesicles having n, n-dimethylamide derivatives as their primary lipid
02/04/1993CA2114122A1 Therapeutic compositions and methods
02/04/1993CA2113817A1 A method for treatment of metabolic disorders
02/04/1993CA2113720A1 Induction of cytotoxic t-lymphocyte responses
02/04/1993CA2113542A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses
02/04/1993CA2113185A1 The preparation of an active substance solution which can be sterilized by filtration
02/03/1993EP0526301A1 Alkyl galactarates, processes for their preparation and applications thereof
02/03/1993EP0525813A1 Water-soluble composition for sustained-release
02/03/1993EP0525740A1 Stevia extract-containing liquid internal medicine and method of preparing the same
02/03/1993EP0525731A2 Seamless capsule and process for producing the same
02/03/1993EP0525655A1 Formulations useful for vaginal dryness treatment
02/03/1993EP0525475A2 A beta-blocker and carbachol containing antiglaucoma composition
02/03/1993EP0525389A2 Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms
02/03/1993EP0525388A1 Suckable or chewable tablet
02/03/1993EP0525333A1 High amylose-content starches for preparing powdery compositions
02/03/1993EP0525307A1 Stable compositions for parenteral administration and their use
02/03/1993EP0525267A2 Prolonged occlusion treatment system
02/03/1993EP0525199A1 Composition containing ultrafine particles of magnetic metal oxide
02/03/1993EP0525177A1 Unimolecular micelles and method of making the same
02/03/1993EP0525167A1 Sustained drug release through topical application of bioadhesive liposomes.
02/03/1993EP0525163A1 Binding of growth hormone to liposomes.
02/03/1993EP0525154A1 Interaction between bioadhesive liposomes and target sites
02/03/1993EP0525132A1 Binding of recognizing substances to liposomes.
02/03/1993EP0525105A1 Polyisobutylene adhesives for transdermal devices.
02/03/1993EP0525055A1 Improved iontophoretic administration of drugs
02/03/1993EP0525039A1 Method and apparatus for inducing transformations in waxes
02/03/1993EP0524987A1 Eriodictyon drug delivery systems
02/03/1993EP0524981A1 Eriodictyon extract pharmaceutical compositions
02/03/1993EP0346343B1 Anti-viral therapeutic composition
02/03/1993CN1068500A Jetting agent for gynaecology disease curing and its preparing process
02/03/1993CN1068494A Compound
02/03/1993CA2075082A1 Prolonged occlusion treatment system
02/02/1993WO1993002661A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
02/02/1993US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
02/02/1993US5183862 Capped polylactones uses as sustained release drug delivery, dispersants, adhesives, binders
02/02/1993US5183829 Oral liquid compositions of non-steroidal anti-inflammatory drugs
02/02/1993US5183802 Mixed with nontoxic effective amount of adsorption enhancer-ammonium glycyrrhizinate and a carrier; used as nose sprays for treatment of osteoporosis
02/02/1993US5183746 Formulation processes for pharmaceutical compositions of recombinant β-
02/02/1993US5183690 Imparting predetermined release properties to an active agent in a starch matrix by extrusion, under specified conditions of a stream containing starch, active agent and water and recovering
02/02/1993US5183666 Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing
02/02/1993US5183662 Controlled drug release composition
02/02/1993US5183589 Stable emulsions of perfluoropolyethers
02/02/1993CA2114225A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
02/02/1993CA2075005A1 Water-soluble composition for sustained-release
02/02/1993CA1313352C Transdermal drug delivery device with dual permeation enhancers
01/1993
01/31/1993WO1993002635A1 Foramenous implant
01/31/1993CA2092825A1 Foramenous implant
01/28/1993DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation
01/28/1993DE4124252A1 Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung Process for the preparation of a sterilized by drug-spoon
01/27/1993EP0524892A1 Method for preparation of an anhydrous solid dispersion